Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanotechnology group to hold national conference in Greensboro

Abstract:
A national group devoted to finding commercial uses for nanotechnology - the science of using tiny particles for business and medical applications - said Thursday it will hold its national conference in Greensboro in August.

Nanotechnology group to hold national conference in Greensboro

Greensboro, NC | Posted on January 10th, 2011

The Micro and Nanotechnology Commercialization Education Foundation plans to hold its Commercialization of Micro-Nano Systems Conference Aug. 28-31 in Greensboro.

The group said that North Carolina is "a hotbed of small technology activity; with 35 nanotech university research centers, over 80 nanobiotech and nanotechnology companies."

Economic and education experts in the state say this type of technology is a key way for the state to attract high-paying jobs and keep its colleges and universities competitive with others around the world.

The Piedmont Triad is one of those centers of development.

In a news release, the foundation says that Greensboro's Joint School of Nanoscience and Nanoengineering and RF Micro Devices are among the organizations that make this state a significant player along with UNC-Chapel Hill and Duke University.

"No other region in the world is such a highly concentrated hub of MNT action," the news release said.

Nanotechnology is used in advanced manufacturing, aerospace and aviation, automotive, biopharmaceuticals, defense, energy, financial services, software and information technology as well as textiles, the foundation said.

Researchers at Greensboro's joint school, in alliance with the Gateway University Research Park, are already working on such advanced composite materials that combine the strength of steel with the flexibility of fabric materials to lighten and strengthen car and aircraft parts.

The foundation said more information will be coming soon about the conference, but did not release location or registration information Thursday.

####

For more information, please click here

Contacts:
Bert Woodard
Next Level Communications www.nextlevelcom.net
336-978-0021

Copyright © Piedmont Triad Partnership

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Jobs

Forge Nano 2017: 1st Quarter Media Update April 20th, 2017

Participate in the development of Malaysia’s National Graphene Action Plan 2020 October 10th, 2016

Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016

SUNY Poly Welcomes DPS as the Global Engineering Firm Opens Its U.S. Advanced Technology Group Headquarters at Cutting-Edge ZEN Building November 20th, 2015

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Events/Classes

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project